University of Virginia
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1819-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.virginia.edu
Study Targeting Myocardial Perfusion and Symptom Relief in Women with SGLT2 Inhibitors (STRONG)
Phase 1
Not yet recruiting
- Conditions
- Angina Patients with Non-obstructive Coronary Artery DiseaseCoronary Microvascular DiseaseCoronary Microvascular Dysfunction (CMD)
- Interventions
- Drug: Placebo
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2025-03-27
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 150
- Registration Number
- NCT06600178
- Locations
- 🇺🇸
UVA Health, Charlottesville, Virginia, United States
Kidney Function in People With Cystic Fibrosis in the Era of HEMT
Recruiting
- Conditions
- Cystic Fibrosis (CF)Chronic Kidney Disease(CKD)Acute Kidney Injury
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2025-04-15
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 260
- Registration Number
- NCT06595420
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸Dartmouth-Hitchcock Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, United States
🇺🇸University of Virginia Children's Hospital, Charlottesville, Virginia, United States
Loss of Y Chromosome in Aortic Stenosis
Recruiting
- Conditions
- Aortic Stenosis
- Interventions
- Diagnostic Test: Blood analysis for loss-of-Y chromosome
- First Posted Date
- 2024-09-13
- Last Posted Date
- 2024-09-13
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 200
- Registration Number
- NCT06595407
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
Evaluating the Anticancer Learning Circle Lifestyle Program in Endometrial Cancer Survivors
Not Applicable
Active, not recruiting
- Conditions
- Neoplasm, Uterine
- Interventions
- Behavioral: Anticancer Learning Circle
- First Posted Date
- 2024-08-13
- Last Posted Date
- 2025-02-28
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 23
- Registration Number
- NCT06550791
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
Pre-Operative Window of ET to Inform RT Decisions (POWER II)
Phase 3
Recruiting
- Conditions
- Breast Cancer Female
- Interventions
- Drug: Tamoxifen, Letrozole, Anastrozole, or Exemestane
- First Posted Date
- 2024-07-18
- Last Posted Date
- 2025-02-10
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 354
- Registration Number
- NCT06507618
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
🇺🇸Virginia Commonwealth University, Richmond, Virginia, United States
Study of EGFRBi Armed Fresh PBMC in Metastatic or Unresectable Pancreatic Cancer
Phase 1
Recruiting
- Conditions
- Pancreas CancerPancreatic Cancer
- Interventions
- Drug: EGFR FPBMC
- First Posted Date
- 2024-06-28
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 23
- Registration Number
- NCT06479239
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
Exercise Training Intensity and Nitrate Supplementation in Post-Menopausal Females
Not Applicable
Not yet recruiting
- Conditions
- Menopause
- Interventions
- Dietary Supplement: Berkeley Life Pro Nitrate CapsulesBehavioral: High Intensity ExerciseBehavioral: Moderate Intensity Exercise
- First Posted Date
- 2024-06-28
- Last Posted Date
- 2024-06-28
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 40
- Registration Number
- NCT06480695
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Early Phase 1
Not yet recruiting
- Conditions
- Advanced Melanoma
- Interventions
- Device: Echopulse or Echopulse HDDrug: PolyICLC
- First Posted Date
- 2024-06-25
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 11
- Registration Number
- NCT06472661
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
Living Alone is Predictive of Non-home Discharge Following Elective Total Hip Arthroplasty: a Matched-pairs Cohort Analysis
Completed
- Conditions
- Arthropathy of HipPerioperative/Postoperative Complications
- Interventions
- Behavioral: home support, hiving aloneBehavioral: home support, living with others
- First Posted Date
- 2024-06-17
- Last Posted Date
- 2024-06-18
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 5677
- Registration Number
- NCT06462885
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
Role of TXA in Patients Undergoing Breast Free Flap Reconstruction
Phase 4
Recruiting
- Conditions
- Breast CancerBlood Loss, Surgical
- Interventions
- Drug: Placebo
- First Posted Date
- 2024-05-24
- Last Posted Date
- 2024-06-05
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 100
- Registration Number
- NCT06428682
- Locations
- 🇺🇸
University of Virginia Medical Center, Charlottesville, Virginia, United States
© Copyright 2025. All Rights Reserved by MedPath